Ципринол

Quick links to important sections

Ципринол

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ципринол

Quick Facts: Ципринол Identity

Property Description
Active ingredient Ciprofloxacin (INN)
Form Oral tablet, solution for injection, ophthalmic and otic solutions
Pharmacological class Fluoroquinolone antibiotic (Second generation)
General purpose Fighting and eliminating bacterial infections
Origin Synthetic

What Type of Medicine is Ципринол and What is it Made Of?

Ципринол is a trade name for a powerful synthetic antimicrobial agent whose active ingredient is Ciprofloxacin. This medication is classified as an antibiotic and specifically belongs to the fluoroquinolone family, which is clinically recognized for its efficacy against a broad spectrum of bacterial infections.

The active pharmaceutical ingredient, Ciprofloxacin (INN), is entirely synthetic in origin, ensuring high purity and consistent pharmacological action. It is a second-generation quinolone with a distinct chemical structure that allows it to achieve broad-spectrum activity. Ciprofloxacin is a single product generally formulated using salts such as Ciprofloxacin hydrochloride. The formulation is specifically authorized for prescription-only (Rx) use, emphasizing its potency and requirement for medical supervision.


General Purpose and Available Forms of Ципринол

The primary general purpose of Ципринол is to fight and eliminate established bacterial infections throughout the body by actively killing the infectious organisms. Its action is bactericidal, achieved by disrupting the bacteria's essential process of DNA replication. The drug is a potent antimicrobial agent used extensively against a wide variety of bacterial pathogens, providing necessary support for managing complex systemic conditions.

To accommodate various therapeutic needs, Ципринол is available in multiple preparation forms that determine its route of administration. It can be administered systemically through an oral tablet or a sterile solution for injection (intravenous). A distinctive feature is its preparation as specialized ophthalmic solution (eye drops) and otic solution (ear drops) for targeted local application. This versatility is crucial, for instance, in managing ear infections where concentrated local treatment is appropriate.

What side effects are possible with Ципринол?

Possible side effects and safety information

Highest-Level Regulatory Warnings and Restrictions

The official safety profile includes a prominent warning for disabling and potentially irreversible serious adverse reactions. These reactions may affect multiple body systems and include effects on tendons, muscles, joints, nerves, and the central nervous system. The use of this medicine is restricted in certain uncomplicated infections where other treatment options are available.

Serious Adverse Reactions and Systemic Organ Classes

The most clinically significant and serious documented adverse reactions are categorized by the systems they affect. These include:

  • Musculoskeletal and Connective Tissue Disorders: Tendinitis, tendon rupture (most commonly the Achilles tendon), muscle pain, and joint pain or swelling. Tendon damage can occur during treatment or several months after discontinuation.
  • Nervous System Disorders: Peripheral neuropathy (nerve damage causing pain, tingling, numbness, or weakness in the arms or legs), confusion, hallucinations, depression, and seizures. These can occur rapidly, even after the first dose.
  • Other Serious Effects: Aortic aneurysm and dissection (a tear in the main artery), severe low blood sugar (hypoglycemia) potentially leading to coma, Clostridioides difficile-associated diarrhea, and life-threatening allergic reactions (anaphylaxis) or skin conditions (e.g., Stevens-Johnson Syndrome).

Frequency-Classified Adverse Reactions

Adverse reactions are classified by frequency as documented in regulatory sources:

Classification Examples of Reactions
Common (1 to 10 out of 100 people) Nausea, diarrhea
Uncommon (1 to 10 out of 1,000 people) Headache, dizziness, sleep disorders, vomiting, abdominal pain, rash, transient liver enzyme elevation
Rare (1 to 10 out of 10,000 people) Tremor, anxiety, confusion, hallucinations, visual disturbances, pseudomembranous colitis, elevated creatinine

Safety Considerations for Specific Populations

The risk of tendon rupture is explicitly higher in patients over 60 years of age, those with renal impairment, and those who have received a solid organ transplant. Concomitant use with systemic corticosteroids should be avoided as it further exacerbates the risk of tendon injury.

Overdose and Emergency Response

Overdose and when to seek help

Documented Overdose Manifestations Official Regulatory Statement
CNS and Neurological Effects Overdose may present with Central Nervous System (CNS) manifestations, including dizziness, tremor, and headache. The official documentation notes the potential for severe events such as convulsions or seizures.
Renal System Excessive exposure affects the renal system, with documented risks of crystalluria (crystal formation in urine) and reversible renal toxicity or acute renal impairment.

Required Emergency Actions and Management

You must seek immediate medical attention upon the suspicion of overdose or the manifestation of any severe symptoms. This action is mandated because regulatory documents explicitly state that no specific antidote is known for Ciprofloxacin overdose.

Management is focused on symptomatic and supportive treatment. Hospital monitoring is required, particularly to observe renal function. To reduce systemic exposure after recent oral ingestion, procedural steps such as gastric lavage and the administration of activated charcoal may be considered. A crucial supportive measure for managing renal risk is the maintenance of hydration. Official labeling notes that patients with pre-existing renal impairment require specific consideration and monitoring.

Therapeutic Uses of Ципринол

What Ciproxin/Cipro (Ciprofloxacin) Treats: Main Uses and Benefits

Ципринол (Ciprofloxacin) is a synthetic, broad-spectrum fluoroquinolone antibiotic used in the management of bacterial infections, generally applied in situations where patients experience certain distressing symptoms. This medicine is commonly used to help with a variety of symptom clusters that may become intense or disruptive across different body systems.


Therapeutic Areas and Condition Categories

Ciprofloxacin is considered relevant for easing the overall symptom burden in numerous conditions characterized by periods of heightened symptoms. It is generally used across several clinical scenarios involving symptoms linked to organ-specific functional stress. This medicine may be part of symptomatic management for conditions presenting with systemic or localized discomfort in the urinary tract, the respiratory system, the gastrointestinal and intra-abdominal area, as well as skin, bone, and joint infections. It is also applied in addressing certain genital tract infections.

Ciprofloxacin provides support that helps ease the overall symptom burden of these acute or disruptive episodes, assisting with maintaining functional stability when symptoms interfere with routine activities. The use of this medicine is generally considered relevant in situations where patients experience symptoms associated with acute or episodic changes.

“This approach supports the patient during difficult episodes by easing distress and helps improve day-to-day comfort during symptomatic periods.”

Quick Fact: Support During Acute Discomfort
Ciprofloxacin is often used during phases when symptoms become more noticeable and supportive symptom management is appropriate, contributing to easing the overall symptom load.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Ципринол

This section describes the official population eligibility rules for Ciprofloxacin (Ципринол), as mandated by government regulatory agencies.


Eligibility Scope

Population Status Classification & Restrictions (Regulatory Basis)
Populations for whom use is allowed Adults (age 18 and older) are generally eligible. Pediatric patients (ages 1 to 17) are eligible only for specific, severe infections such as Complicated UTI/Pyelonephritis, Inhalational Anthrax (Post-Exposure), and Plague [Source 1.4, 2.4].
Populations for whom use is contraindicated Patients with known hypersensitivity to Ciprofloxacin or any other fluoroquinolone are strictly prohibited. Concomitant use with tizanidine is also absolutely contraindicated [Source 2.4].
Age-related eligibility rules General use in children under 18 is not recommended due to musculoskeletal risks. Older adults are eligible but face an officially noted increased risk for severe tendon disorders [Source 4.1].

Condition-Specific and Reproductive Status Eligibility

Condition-specific eligibility rules:

  • Patients with reduced renal function are eligible only if a mandatory dosage adjustment is implemented according to their creatinine clearance [Source 1.1, 2.3].
  • Patients with a history of myasthenia gravis must avoid this medicine due to the risk of exacerbation of muscle weakness [Source 1.4].
  • Use requires caution in patients with a known risk for QT interval prolongation [Source 1.4].

Pregnancy and lactation eligibility status:

  • Pregnancy: Use is restricted and permitted only if the potential benefit is deemed to justify the potential risk, as per regulatory classification [Source 3.4].
  • Lactation: Use is not recommended, and the drug passes into human milk. Breastfeeding should be avoided during treatment and for two days after the final dose [Source 4.4].

Connection to the overall eligibility profile: The regulatory profile clearly defines who can and cannot use the medicine by establishing absolute prohibitions (e.g., tizanidine use) and imposing severe constraints on age and organ function. Eligibility for restricted groups is conditional, requiring specific medical rationale or mandatory dose modifications to proceed with treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Ciprofloxacin (Ципринол) establishes specific interaction-related constraints across several domains. The most critical restriction is the formal contraindication of co-administration with Tizanidine, as Ciprofloxacin is documented as an inhibitor of Cytochrome P450 1A2 (CYP1A2). This inhibition significantly increases Tizanidine's systemic exposure and potentiates its hypotensive and sedative effects.


Pharmacokinetic and Absorption Constraints

Interaction Type Interacting Substance Regulatory Outcome
Absorption Interference Multivalent Cations (e.g., Iron, Antacids) Ciprofloxacin absorption is significantly reduced via **chelation** (by up to 90%).
Metabolic Inhibition Theophylline, Caffeine Ciprofloxacin **decreases the clearance** of these agents, resulting in **elevated serum levels**.
Renal Clearance Competition Probenecid Interferes with Ciprofloxacin's **renal tubular secretion**, **increasing its serum level**.

Pharmacodynamic and Timing Rules

Ciprofloxacin's interaction profile includes requirements for monitoring and dose separation. Co-administration with oral anticoagulants (e.g., Warfarin) is reported to enhance the anticoagulant effect, necessitating close monitoring. Combining Ciprofloxacin with Corticosteroids is associated with an increased risk of tendinitis and tendon rupture, a risk noted as potentially increased in elderly patients. Due to the absorption interference, Ciprofloxacin must be administered at least 2 hours before or 6 hours after multivalent cation-containing products.

Mechanism of Action

How Ципринол Works


Blocking Essential Bacterial Genetic Management

This mechanism involves Ципринол (Ciprofloxacin) acting as an inhibitor against two bacterial enzymes: DNA Gyrase and Topoisomerase IV. The drug binds to and poisons these enzymes, which are responsible for maintaining the structure and replication of the bacterial DNA. This inhibition of DNA Gyrase and Topoisomerase IV creates a functional block in the bacterial cell.


The Bactericidal Cascade: Irreversible DNA Damage

The enzyme poisoning leads directly to the creation of double-strand DNA breaks within the bacterial cell. This structural damage activates the pathogen’s internal stress response, which ironically accelerates the degradation of its own genetic material. This bactericidal (cell-killing) mechanism initiates a concentration-dependent elimination of the bacterial population.


Understanding Mechanistic Limits: Resistance Factors

The mechanism can be weakened by two main bacterial defense mechanisms: mutations in the enzyme binding site (QRDR) and the activation of efflux pumps. These limitations either prevent the drug from binding effectively to its target or actively pump it out of the cell, reducing the concentration available to execute the lethal action. Changes in bacterial structure can constrain the mechanism's physiological effect.

Dosage and Administration Information

Official Administration Routes and Forms

Ciprofloxacin (Ципринол) is formally approved for systemic administration via oral tablets or intravenous (IV) infusion for internal infections, reflecting its versatility in patient care. It is also supplied in specialized ophthalmic and otic solutions for targeted local application. IV solutions are typically administered slowly, requiring an infusion duration of 60 minutes to ensure proper delivery.


Standard Dosage and Frequency

Systemic dosing regimens are specifically defined. The standard adult regimen for immediate-release formulations typically uses doses between 250 mg and 750 mg per dose, administered twice daily (every 12 hours). Extended-release oral forms are designated for once-daily use. The official protocol often guides the transition from initial IV therapy to an equivalent oral dosage as part of sequential therapy when clinically appropriate.


Administration Conditions and Adjustments

Oral tablets may be taken with or without food but must be separated by several hours from the consumption of dairy products or calcium-fortified juices, as these items interfere with absorption. A dose reduction or interval extension is formally required for patients with documented reduced renal function, as official prescribing information specifies adjustments for creatinine clearance <50 mL/min. The overall treatment duration is highly variable, ranging from a single dose up to a course lasting as long as 60 days for specific conditions.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ципринол (Ciprofloxacin)

The clinical evidence for Ciprofloxacin (Ципринол) derives from controlled trials and observational studies referenced by regulatory bodies. This research helps describe the observations made in studies evaluating the medicine across various bacterial infections and patient groups.


Evidence for Infections of the Urinary Tract and Prostate

Research has explored the evaluation of Ciprofloxacin for conditions characterized by fluctuating or episodic manifestations in the urinary system. Studies conducted include randomized controlled trials (RCTs) where Ciprofloxacin was compared to other established antimicrobial treatments. These studies monitored short-term outcomes related to bacteriological eradication—a measured endpoint indicating the clearance of the infectious organism—and the evolution of symptoms linked to systemic or functional imbalance. Studies reported measurements of clinical success rates within short follow-up periods.

The evidence for long-term clinical outcomes in chronic bacterial prostatitis is limited in many studies. Furthermore, research highlights a growing concern regarding antimicrobial resistance patterns among common urinary pathogens, which may influence the consistency of findings reported across different global study settings.


Evidence for Acute and Chronic Respiratory Infections

Research examined Ciprofloxacin's role in respiratory conditions, including pneumonia and acute exacerbations of chronic bronchitis. Trials monitored outcomes related to symptom evolution and measurements of microbiological clearance rates against specific pathogens. Specialized, longer-term studies on inhaled forms were applied in research contexts involving fluctuating or unstable symptoms in populations like those with Cystic Fibrosis (CF).

Data show patterns related to drug concentration achieved in lung tissue, but optimal duration and dosing for the specialized inhaled forms in chronic conditions are not fully established. Additionally, the long-term impact of cyclical use on the development of resistance patterns is still emerging and not fully defined across all patient groups.

Key Studies & References

  1. Ciprofloxacin Bayer Summary of Product Characteristics (SmPC) (EU/UK Regulator Document)
  2. Ciprofloxacin for Post-Exposure Prophylaxis of Anthrax - Emergency Use Instructions for Healthcare Providers (FDA/CDC Guidance)

Frequently Asked Questions (FAQ)

Common questions about Ципринол (FAQ)


Q: How quickly does Ciproxin start working?

Official pharmacokinetic data indicates that the highest concentration of the active substance in the blood is typically reached between 1 and 4 hours after taking an oral dose. However, the time it takes for a patient to observe a clinical reduction in symptoms can vary based on the specific type and severity of the bacterial infection being treated.


Q: What should not be combined with Ciproxin?

Regulatory information states that this medicine is strictly contraindicated (forbidden) for use with the drug Tizanidine. Other items, such as antacids, iron supplements, or products rich in multivalent cations, must be separated by several hours, as they can significantly reduce the medicine's absorption.


Q: What are the most common side effects of Ciproxin?

According to official regulatory documents, the most frequently reported side effects are categorized as 'common,' meaning they affect 1 to 10 out of every 100 people. These commonly reported effects include nausea and diarrhea.


Q: Can Ciproxin be taken during pregnancy?

Official regulatory classifications note that the use of this medicine during pregnancy is restricted. It is only permitted if the prescribing physician determines that the potential benefit justifies the potential risks to the developing fetus.


Q: How does Ciproxin interact with dairy products?

Regulatory administration rules state that the oral dose must be separated from dairy products and calcium-fortified juices by at least two hours. These products contain multivalent cations that bind to the medicine in the stomach, a process called chelation. This binding significantly interferes with and reduces the absorption of the active substance into the body.


Q: Is it true that Ciproxin affects joints and ligaments?

Yes, official drug warnings explicitly describe the potential for effects on the musculoskeletal system. These include reports of tendinitis, tendon rupture, and joint pain or swelling. These effects are officially noted as potentially disabling and sometimes irreversible.


Q: How many days is Ciproxin usually taken?

The duration of treatment is highly variable, depending entirely on the specific infection and patient circumstances, ranging from a single dose to a course of up to 60 days. Official prescribing information for common infections often describes treatment courses that typically last between 7 and 14 days.


Q: What happens if a dose of Ciproxin is missed?

Official guidance describes that if a dose is missed, patients are generally instructed to take it as soon as it is remembered. Patients are explicitly warned not to take two doses simultaneously or exceed the official daily dosage limit to compensate for the missed administration.


Q: What should be done if two doses of Ciproxin are accidentally taken?

Regulatory information on overdose notes that an acute, accidental overdose may potentially result in reversible kidney toxicity. As is standard protocol for any suspected overdose of a prescription drug, regulatory bodies state that immediate professional medical attention is required.


Q: Can side effects from Ciproxin appear a week after finishing the course?

Yes, official warnings for serious adverse reactions, particularly those involving the tendons, note that they can occur not only during treatment but also up to several months after the medicine has been discontinued.


Q: Is Ciproxin allowed for children and from what age?

General use is not recommended for children and adolescents under 18 due to official concerns regarding musculoskeletal risks. However, the medicine is officially permitted for pediatric patients aged 1 year and older only for a small number of specific, severe infections like complicated urinary tract infections or anthrax.


Q: What should be done if a severe rash appears after taking Ciproxin?

Regulatory guides specify that if signs of a serious allergic reaction, such as a severe rash, hives, or skin peeling, appear, the medicine should be stopped immediately. Regulatory guides specify that emergency medical help is required immediately in such cases.


Q: What does 'sensitivity to light' mean when taking Ciproxin?

Sensitivity to light, or photosensitivity, is a documented side effect, meaning the skin may react abnormally to ultraviolet light from the sun or sunlamps. Official guidelines describe protective measures, such as avoiding direct sun exposure and using protective clothing or sunscreen, that are generally advised while taking the medicine.


Q: Ciproxin and alcohol – what information is there in official sources?

Official drug labels and prescribing information generally do not list alcohol as a direct contraindication. However, authoritative healthcare bodies note that alcohol consumption could potentially intensify some of the drug's known central nervous system side effects, such as dizziness and drowsiness.


Q: Is Ciproxin available as a suspension or only as tablets?

The medicine is formally approved and manufactured in multiple preparations to accommodate different therapeutic needs. It is available not only as oral tablets and solutions for injection but also as a sterile oral suspension (liquid form) and specialized ophthalmic and otic solutions.


Q: How long can residual effects last after a course of Ciproxin?

Official safety communications have reported that disabling and potentially permanent side effects involving the tendons, nerves, or central nervous system have been observed. For some individuals, these effects have been noted to continue for months to years after the drug was stopped.


Q: Is Ciproxin dangerous with long-term use?

The duration of use is strictly determined by the prescribing criteria for the specific infection being treated. Official warnings state that the medicine is associated with serious, potentially disabling side effects affecting multiple body systems (tendons, nerves, CNS). Because of these risks, its use is restricted in some less severe infections where alternative treatments are available.


Q: Is it true that Ciproxin can cause heart problems?

Official drug labels caution that this medicine can cause a risk for QT interval prolongation, which is a specific type of abnormal heart rhythm. Furthermore, the risk of aortic aneurysm and dissection (a tear in the main artery) is also documented, requiring caution in at-risk patients.


Q: Can Ciproxin be taken with vitamins or supplements?

Official warnings highlight that products containing multivalent cations like iron, calcium, or zinc, which are common in many vitamins and supplements, can interfere with absorption. To mitigate this, official rules state that the oral dose must be separated from these supplements by at least 2 hours before or 6 hours after the medicine.


Q: Does Ciproxin affect the results of blood or urine tests?

Official regulatory information advises that this medicine may affect the results of certain laboratory tests. Therefore, patients are instructed to inform all healthcare providers and laboratory personnel that they are taking the drug before any blood or urine analysis is conducted.


Q: How can one know if Ciproxin is appropriate versus another antibiotic?

The choice between this and another antimicrobial is a clinical decision made by a healthcare professional. Official guidelines emphasize that this medicine is used to treat infections caused by bacteria that have been confirmed or are strongly suspected to be susceptible to Ciprofloxacin based on specific laboratory testing.


Q: Is there any connection between Ciproxin and increased anxiety?

Official adverse event reports list anxiety as an uncommon or rare side effect associated with the medicine. The drug is known to affect the central nervous system, and other documented effects in this class include confusion and hallucinations.


Q: Is it necessary to follow a special diet while taking Ciproxin?

A specific overall diet is not generally required by regulatory documents. However, a key administration rule is mandatory: the oral dose must be separated by several hours from dairy products and calcium-fortified juices to prevent absorption interference.


Q: What should be done if the stomach hurts after taking Ciproxin?

Abdominal pain and discomfort are documented as uncommon side effects of this medicine. Official guidance states that any patient experiencing persistent or severe gastrointestinal issues, especially severe, watery, or bloody diarrhea, is directed to contact their healthcare provider, as this could be a sign of a serious infection like pseudomembranous colitis.


Q: Can Ciproxin be taken with oral contraceptive pills?

Official drug labels generally state that this medicine does not have a consistent, clinically significant interaction that reduces the effectiveness of all hormonal contraceptives. However, some regulatory reports mention that it may reduce the effectiveness of certain components, and patients are generally directed to consult their healthcare provider about the potential need for alternative contraception during the course of treatment.


Q: What information is available about using Ciproxin for infection prevention?

Official prescribing information includes the use of this medicine for prophylaxis (prevention) of certain specific infections. The most prominent example is its use following exposure to pathogens, such as post-exposure inhalational anthrax.


Q: Is there official information about the effect of Ciproxin on gut microflora?

Official regulatory warnings indirectly confirm an effect on gut microflora (the natural balance of organisms) by noting the risk of C. difficile-associated diarrhea. This is a serious condition that can occur when broad-spectrum antibiotics disrupt the normal balance in the gut, leading to the overgrowth of harmful bacteria.

How should Ципринол be stored and disposed of?

Storage and Disposal of Ciprofloxacin (Ципринол)

Official regulatory guidelines define specific conditions to maintain the stability of ciprofloxacin formulations.

Required Storage Conditions

Formulation Required Storage Condition
Oral Tablets Store below 30 C (86 F) in a tight container; protect from intense ultraviolet light.
Reconstituted Suspension Stable for 14 days when stored below 30 C (86 F). Must not be frozen.

All forms of the medicine must be stored out of the reach and sight of children.

Disposal

Discard any unused or expired product by consulting a healthcare professional or pharmacist and following local requirements for proper pharmaceutical waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ципринол found in:

A-Z Index: